Chemotherapy of thyroid carcinoma

Journal of Endocrinological Investigation
S Ahuja, H Ernst

Abstract

On the basis of 8 patients of our own and a survey of the literature, the present state of chemotherapy of thyroid carcinoma is discussed. Chemotherapy is only indicated in cases of progressing disease after exhaustion of all conventional therapies. Only in cases of undifferentiated giant- or spindle-cell thyroid carcinomas can chemotherapy following conventional treatment be approved right from the beginning. The three most widely applied cytostatics are adriamycin, bleomycin and cis-platinum, and it seems that adriamycin monotherapy, is superior to all other therapies, even combinations, except probably for the undifferentiated thyroid carcinoma. In addition to the patient's general condition, a sufficiently high single dose of adriamycin, which should be increased in case of nonresponse, appears to be essential for the therapeutical effect. Due to its low toxicity, especially cardiotoxicity, 4'-epi-adriamycin, which, while being almost as effective, can be applied at higher doses and over longer periods, seems to be promising. Approximately 1/3 of thyroid carcinomas respond to adriamycin monotherapy, the response rate probably being highest for medullary types and lowest for undifferentiated thyroid carcinomas. The highest r...Continue Reading

References

Jan 1, 1977·Zeitschrift Für Krebsforschung Und Klinische Onkologie. Cancer Research and Clinical Oncology·K KolarićJ Krusić
May 1, 1977·Cancer·R M O'BryanB Hoogstraten
Apr 1, 1972·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G BonadonnaF Fossati-Bellani
Feb 1, 1974·British Journal of Cancer·M P ColeP M Wilkinson
Jul 1, 1971·American Journal of Surgery·T HaradaS Baba
Mar 18, 1983·Deutsche medizinische Wochenschrift·G Benker, D Reinwein
Jul 1, 1980·Clinics in Endocrinology and Metabolism·R D Leeper, K Shimaoka

❮ Previous
Next ❯

Citations

Sep 16, 1998·Thyroid : Official Journal of the American Thyroid Association·K B Ain
Jan 31, 2006·Arquivos brasileiros de endocrinologia e metabologia·Hans Graf
Dec 24, 2010·The Korean Journal of Internal Medicine·Kyu-Hyoung LimJong Seok Lee
Nov 8, 2012·Clinical Medicine Insights. Oncology·H A DeshpandeS Roman
Feb 6, 2018·Therapeutic Advances in Medical Oncology·Laurence FaugerasLionel D'Hondt
Dec 20, 2002·Current Opinion in Oncology·Janice L Pasieka
Dec 22, 2004·Current Treatment Options in Oncology·Jyotika K FernandesAnand K Sharma
Aug 17, 2006·Thyroid : Official Journal of the American Thyroid Association·Lisa K GilliamCheryl A Pickett
Dec 23, 2009·Thyroid : Official Journal of the American Thyroid Association·Takuya HigashiyamaAkira Miyauchi
Sep 29, 2011·Medical Oncology·Jean-Philippe SpanoL Leenhardt
Aug 13, 2011·Clinical Medicine Insights. Oncology·Hari DeshpandeJulie Ann Sosa
Apr 25, 2012·Journal of Thyroid Research·Naifa Lamki Busaidy, Maria E Cabanillas
Sep 27, 2005·Arquivos brasileiros de endocrinologia e metabologia·Pedro Weslley S RosárioSaulo Purisch
Oct 12, 2000·Journal of Surgical Oncology·M J BoyleW Mnaymneh
Feb 3, 2007·Head & Neck·Tae Yong KimYoung Kee Shong
Aug 20, 2010·Thyroid : Official Journal of the American Thyroid Association·Huan T HaFrancis P Worden
Mar 28, 2013·Case Reports in Oncological Medicine·Nasir HussainAlan D Gilman
Apr 28, 2017·Molecular Medicine Reports·Hong-Yan ShenYu-Jun Gao
Jan 16, 1999·Seminars in Surgical Oncology·K B Ain
Feb 14, 2006·Annals of Surgical Oncology·Chandrakanth Are, Ashok R Shaha
Jun 1, 2006·Cancer Control : Journal of the Moffitt Cancer Center·Kepal N Patel, Ashok R Shaha
Jul 21, 2011·Journal of Oncology·Govardhanan NagaiahScot C Remick
Mar 5, 2010·Japanese Journal of Clinical Oncology·Kenji KawadaYuichi Ando
Oct 5, 2010·Southern Medical Journal·Constantin A Dasanu
Feb 1, 1997·Thyroid : Official Journal of the American Thyroid Association·J C MorrisJ I Mechanick
Jan 1, 1990·Journal of Cancer Research and Clinical Oncology·H ScherüblR Ziegler
Jan 24, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Seungwon KimJeffrey N Myers
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Fernando Gomez-RiveraJeffrey N Myers
Mar 1, 1993·American Journal of Otolaryngology·Y L Colson, S E Carty

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
P J Hoskin, C Harmer
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy
M J Krzakowski, J Swierz
© 2021 Meta ULC. All rights reserved